Status:
UNKNOWN
Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy
Lead Sponsor:
Nabil Mahmoud Ismail Abdel-Aal
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Effect of exergaming exercises and mediteranean diet on thyroid cancer patients following total thyroidectomy adult patients from both gender will be randomly assigned equally to exergaming exercises,...
Detailed Description
Outcome measures 1. Flow cytometry analyzer for NKC (CD3- CD16+ CD56+). 2. Immunoassay analyzer for thyroid profile (TSH,T3,T4) 3. Quality of life questionnaire 4. Fatigue questionnaire 5. PREDIMED q...
Eligibility Criteria
Inclusion
- Diagnosis of thyroid papillary carcinoma as it is the most common type
- Treatment with thyroid hormone medication after thyroidectomy
- Lack of radioactive iodine treatment within the past 6 months
- Blood hemoglobin level \>10 g/dL.
- Not taking drugs that could affect their immune function (e.g., immunosuppressants such as cyclosporin and steroids .
- Lack of regular exercise
- Age 18\~45 years
- Dose should be controlled at the first one year
- \-
Exclusion
- 1\) Abscess or inflammation suspected by preoperative tests 2) Patients with stage IV cancer and with limited understanding of assessment systems 3) History of head or neck malignancy . 4) Radiation therapy 5) Graves disease 6) Thyroiditis 7) Orthopaedic and rheumatic conditions of the neck . 8) The patient's inability to cooperate
- \-
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 5 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05265819
Start Date
March 1 2022
End Date
December 5 2022
Last Update
March 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.